AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $755,306 | +363.4% | 62,114 | +266.6% | 0.00% | +100.0% |
| Q2 2021 | $163,000 | -85.0% | 16,945 | -64.1% | 0.00% | -83.3% |
| Q4 2020 | $1,090,000 | -88.2% | 47,199 | -93.6% | 0.01% | -92.1% |
| Q2 2019 | $9,263,000 | +101.5% | 742,236 | +119.6% | 0.08% | +245.5% |
| Q1 2019 | $4,598,000 | +203.5% | 338,002 | +113.8% | 0.02% | +46.7% |
| Q4 2018 | $1,515,000 | -94.6% | 158,090 | -93.2% | 0.02% | -87.5% |
| Q3 2018 | $28,192,000 | +7954.9% | 2,331,882 | +3537.5% | 0.12% | +3900.0% |
| Q2 2016 | $350,000 | -40.8% | 64,107 | +51.8% | 0.00% | -57.1% |
| Q3 2015 | $591,000 | -87.2% | 42,224 | -87.0% | 0.01% | -88.3% |
| Q2 2015 | $4,603,000 | -64.6% | 325,268 | -72.8% | 0.06% | -64.5% |
| Q1 2015 | $13,007,000 | +23.2% | 1,195,514 | -5.8% | 0.17% | +21.6% |
| Q4 2014 | $10,560,000 | +831.2% | 1,269,229 | +273.9% | 0.14% | +717.6% |
| Q2 2014 | $1,134,000 | – | 339,443 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |